Elauwit Q2 FY26 net loss widens to $3.1 million; revenue drops 46% to $2.9 million YoY
Reuters2026/08/18 10:31- Elauwit Connection posted Q2 revenue of USD 2.9 million, down 46% year over year, with net loss widening to USD 3.1 million.
- Contracted units climbed 16% quarter over quarter to 42,687, up 33% from a year earlier.
- Activated units rose to 27,134, up 94% year over year; billed units more than doubled to 22,967, up 163%.
- Backlog increased to USD 38.9 million from a year earlier; cash totaled USD 1.2 million, with total debt at USD 2.2 million.
- Management expects contracted units to exceed 50,000 before year-end, with new construction weighted to the second half of 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
